| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA2419634
Max Phase: Preclinical
Molecular Formula: C31H41N5O14
Molecular Weight: 707.69
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CON(CC(=O)Nc1ccc2c(c1O)C(=O)C1=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]1[C@H]2C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1N
Standard InChI: InChI=1S/C31H41N5O14/c1-9-10-5-6-11(34-13(38)7-36(49-4)30-19(32)26(44)22(40)12(8-37)50-30)21(39)15(10)23(41)16-14(9)24(42)18-20(35(2)3)25(43)17(29(33)47)28(46)31(18,48)27(16)45/h5-6,9,12,14,18-20,22,24,26,30,37,39-40,42-45,48H,7-8,32H2,1-4H3,(H2,33,47)(H,34,38)/t9-,12+,14+,18+,19+,20-,22+,24-,26+,30+,31-/m0/s1
Standard InChI Key: AIMDETINAQPCES-ICZJHBKASA-N
Associated Targets(Human)
IMR-90 216 Activities
A549 127892 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Associated Targets(non-human)
Staphylococcus aureus 210822 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Escherichia coli 133304 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 707.69 | Molecular Weight (Monoisotopic): 707.2650 | AlogP: -3.78 | #Rotatable Bonds: 8 |
| Polar Surface Area: 319.13 | Molecular Species: ACID | HBA: 17 | HBD: 11 |
| #RO5 Violations: 3 | HBA (Lipinski): 19 | HBD (Lipinski): 13 | #RO5 Violations (Lipinski): 3 |
| CX Acidic pKa: 2.87 | CX Basic pKa: 7.97 | CX LogP: -7.58 | CX LogD: -7.56 |
| Aromatic Rings: 1 | Heavy Atoms: 50 | QED Weighted: 0.07 | Np Likeness Score: 1.16 |
References
| 1. Zhang J, Ponomareva LV, Marchillo K, Zhou M, Andes DR, Thorson JS.. (2013) Synthesis and antibacterial activity of doxycycline neoglycosides., 76 (9): [PMID:23987662] [10.1021/np4003096] |
Source
Source(1):